ALC:NYSE
Alcon AG
$63.00
arrow_downward
-0.30%(-0.19) 1D
Okt 7, 4:00:06 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALC...
Buksan
$63.36
Mataas
$63.68
Mababa
$62.94
Mkt. cap
26.62B
Avg. na dami
1.61M
Dami
1.17M
Mataas nang 52-wk
$87.64
Mababa nang 52-wk
$61.84
Beta
0.88
Mga natitirang share
483.40M
Bilang ng mga empleyado
25K
Buksan
$63.36
Mataas
$63.68
Mababa
$62.94
Mkt. cap
26.62B
Avg. na dami
1.61M
Dami
1.17M
Mataas nang 52-wk
$87.64
Mababa nang 52-wk
$61.84
Beta
0.88
Mga natitirang share
483.40M
Bilang ng mga empleyado
25K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
3 oras ang nakalipas
EUR 56.57 at Lang & Schwarz: Alcon stock after-hours plus 0.86 percent versus the prior close
AD HOC NEWS
·
8 oras ang nakalipas
Alcon stock trades at CHF 52.90 before November 10 earnings
AD HOC NEWS
·
1 araw ang nakalipas
Alcon stock after-hours at EUR 56.24: minus 1.88 percent versus the Lang & Schwarz prior close
AD HOC NEWS
·
2 araw ang nakalipas
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Tungkol sa Alcon AG
CEODavid J. Endicott
Mga Empleyado25K
Itinatag1945
HeadquartersHinebra, Geneva, Switzerland
Sektor-
Websitealcon.com